Hims & Hers Health
HIMS
486 hedge funds and large institutions have $5.96B invested in Hims & Hers Health in 2025 Q4 according to their latest regulatory filings, with 99 funds opening new positions, 180 increasing their positions, 158 reducing their positions, and 121 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 180 | Existing positions reduced: 158
5% less funds holding
Funds holding: 512 → 486 (-26)
8.29% less ownership
Funds ownership: 91.88% → 83.59% (-8.3%)
18% less first-time investments, than exits
New positions opened: 99 | Existing positions closed: 121
21% less call options, than puts
Call options by funds: $946M | Put options by funds: $1.19B
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
47% less capital invested
Capital invested by funds: $11.3B → $5.96B (-$5.38B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$77.3M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$72.2M |
| 3 |
MG
Marex Group
London,
|
+$64.1M |
| 4 |
BlackRock
New York
|
+$61.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$60.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$315M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$191M |
| 3 |
Renaissance Technologies
New York
|
-$183M |
| 4 |
Morgan Stanley
New York
|
-$143M |
| 5 |
TI
Tidal Investments
Milwaukee,
Wisconsin
|
-$118M |
HIMS Hedge Fund Activity: Q4 2025 in Review
486 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q4 2025, worth a combined $5.96B — down 47% from $11.3B a quarter earlier.
Sellers outnumbered buyers: 121 funds closed out of HIMS and 99 opened new positions — a net loss of 22 holders — while 158 trimmed existing stakes and 180 added.
The largest buyer was Citadel Advisors, adding an estimated $77.3M. The largest seller was Farallon Capital Management, cutting an estimated $315M.
- 486 institutional investors held Hims & Hers Health (HIMS) as of Q4 2025, down from 512 in Q3 2025.
- Funds reported $5.96B of Hims & Hers Health stock for Q4 2025, down 47% quarter-over-quarter.
- 99 funds opened new Hims & Hers Health positions in Q4 2025 and 121 closed out, a net change of -22 holders.
- The largest Hims & Hers Health buyer in Q4 2025 was Citadel Advisors, an estimated $77.3M added.
- The largest Hims & Hers Health seller in Q4 2025 was Farallon Capital Management, an estimated $315M sold.
Based on aggregated 13F filings for Q4 2025.